The mechanism underlying persistent hepatitis B virus (HBV) infection remains unclear. We
investigated the role of innate immune responses to persistent HBV infection in 154 HBV …

The efficacy of entecavir and tenofovir in patients with chronic hepatitis B virus (HBV) is
inconsistent. To address this issue, we conducted a meta‐analysis based on a current …

Abstract Background and Aim Studies focused on the naturally occurring resistance
mutation rate in treatment‐naïve chronic hepatitis B (CHB) patients have set off a furious …

Mother-to-child transmission is the major cause of chronic hepatitis B virus (HBV) infection.
This double-blind trial tested the effect of tenofovir disoproxil fumarate (TDF) in preventing …

Background HBeAg-positive chronic infection is a unique phase of chronic hepatitis B virus
(HBV) infection. Current guidelines advise against starting antiviral treatment for HBeAg …

China has nearly 10% of the general HBV carrier population in the world; this infection is the
most common cause of chronic liver disease. Understanding HBV epidemiology is essential …

Hepatitis B virus (HBV) infection is a critical global health issue and moderately epidemic in
Western China, but HBV molecular epidemiology characteristics are still limited. We …

This study was performed to analyze the potential resistant mutations within HBV reverse
transcriptase (RT) sequences against nucleos (t) ide analogues (NA). HBV DNA RT region …

Background The study aimed to develop an effective method to quantitate HBV covalently
closed circular DNA (cccDNA) using small section of formalin fixed paraffin-embedded …

Glioma is one of the most destructive human tumours. Although standard treatment has
improved the prognosis for glioma patients, the survival of glioma patients is still …